Innovative Healthcare
Payor Platform in China
Innovative Healthcare
Payor Platform in China
We are committed to transforming the country’s healthcare payment system through digitalization and artificial intelligence.We bring together the core needs of patients, health insurers, and pharmaceutical companies to provide end-to-end solutions across the entire healthcare ecosystem—from pharmaceuticals and medical devices to insurance, payments, and services—continuously optimizing collaborative mechanisms for diversified payment systems.
Mind.42.ai is a professional artificial intelligence core platform independently developed by MediTrust Health. Targeting the pharmaceutical and insurance sectors, it is designed to enhance the stability, efficiency and sustainability of the healthcare payment and service system.
Customized intelligent solutions for pharmaceutical companies and insurance firms
Reliable protection for patients and policyholders
We are dedicated to delivering more comprehensive,
quality and accessible healthcare for patients and their families.
Out-of-pocket Costs
Saved for Patients
Cities Covered by City Supplementary Insurance
Cities Covered by City
Supplementary Insurance
Featured
Collaborations
Relying three core infrastructures—diversified pharma payment platform, pharma supply chain network and AI intelligent hub, MediTrust Health and Mabwell have forged in-depth strategic cooperation. Together, they will build a closed-loop "Internet + Healthcare + Pharma + Insurance" system across the full pharma lifecycle, enhancing innovative drug accessibility and affordability for patients.
MediTrust Health and Sino Biopharmaceutical have forged a strategic cooperation, pioneering a new model of pharma-insurance integration. Through an integrated “diagnosis, treatment & payment” solution, we alleviate the burden on patients and build a data-driven ecosystem to enhance the accessibility and affordability of pharmaceuticals and medical devices, and set a benchmark for industrial collaboration.
As a key alliance member, MediTrust Health serve as the critical infrastructure for the diversified payment ecosystem. Leveraging its platform strengths in connection and empowerment, it drive the integration of innovative pharma, medical devices and insurance, delivering core platform value to improve accessibility and affordability of innovative drugs in China.
MediTrust Health and Funde Sino Life have forged a strategic cooperation to provide customers with an end-to-end solution system featuring "quality medical care, quality pharmaceuticals and quality payment". Through a single insurance policy, we connect top-tier medical resources, advanced pharmaceuticals and convenient payment experiences.
MediTrust Health and China Re HK have partnered to launch cross-border healthcare solutions. Focusing on pharmaceutical accessibility, healthcare connectivity and payment simplification, we address key pain points for Hong Kong residents seeking medical care in the Chinese mainland.
MediTrust Health carries out in-depth cooperation with New China Life Insurance and China Re Life. Focusing on coverage including out-of-hospital pharmaceuticals & devices, critical illness special needs and minor hospitalization, we center on medical treatment, medication and payment. Empowered by quality medical resources and innovative payment solutions, we fully upgrade customers’ health service experience.
By leveraging our extensive capabilities in specialty drug services , from formulary design and AI-supported claims review to direct billing infrastructure , we enabled AIA Life Insurance to deliver differentiated value across both flagship high-end and inclusive insurance offerings, which spans more than 2.5 million policies.
By leveraging our extensive capabilities in specialty drug services , from formulary design and AI-supported claims review to direct billing infrastructure, we enabled AIA Life Insurance to deliver differentiated value across both various insurance offerings.
As the platform to support all five commercially approved CAR-T therapies in China, we offer an end-to-end solution spanning market access, innovative payment models, and patient management services, tailored to the unique needs of hematologic malignancies.
As the platform to support all five commercially approved CAR-T therapies in China, we offer an end-to-end solution spanning market access, innovative payment models, and patient management services, tailored to the unique needs.
One-Stop Medical
and Commercial Insurance Settlement
The Commercial Insurance Code launched by Alipay and partnered with Taikang Online is powered by MediTrust Health’s technology. This solution enables seamless commercial insurance advance payment after medical payments, boosting settlement efficiency and hospitalization experience.
The Commercial Insurance Code launched by Alipay and partnered with Taikang Online is powered by MediTrust Health’s technology. This solution enables seamless commercial insurance advance payment after medical payments, boosting the settlement efficiency.
Gilead’s breakthrough breast cancer drug, Trodelvy, is now available on the Care2Pay platform, marking the first integration of “CSI + Pre-existing Condition Insurance.” This solution provides transparent co-payment billing, supports one-stop claims, and creates an affordable, sustainable payment pathway for patients.
Gilead’s breakthrough breast cancer drug, Trodelvy, realized the first integration of “City Supplementary Insurance + Pre-existing Condition Insurance" at Care2Pay. This solution provides one-stop claims, and creates an affordable and sustainable payment pathway.
Addressing evolving health needs, MediTrust Health integrates “top experts, advanced medications, Care2Pay” into this product, breaking barriers to premium medical resources and innovative drugs, delivering high-quality healthcare and payment services directly to clients.
Addressing evolving health needs, MediTrust Health integrates “top experts, advanced medications, Care2Pay” into this product, breaking barriers to advanced medical products, delivering high-quality healthcare and payment services directly to clients.
As a comprehensive service operator, MediTrust Health supports “HuiMinBao” with end-to-end services, introducing dual-plan options, expanding high-value specialty drug coverage, and improving claims efficiency to boost participation and retention rates.
In partnership with HSBC Premier, MediTrust Health offers triple-protection plans with seven health benefits, covering daily medical needs, pharmaceutical services, health management, and senior care. We connect online and offline, domestic and international premium medical resources to safeguard family health.
IIn partnership with HSBC Premier, MediTrust Health offers healthcare plans covering daily medical needs, medication services, health management, and senior care. We connect online and offline, domestic and international premium medical resources to safeguard family health.
Akeso, in partnership with MediTrust Health, pioneers Therapeutic-Result-Linked n insurance solutions. Upgrading from medication access to holistic health management, this model leverages intelligent risk control and dynamic anti-fraud claims verification systems, delivering benefits for pharmas, insurers, and patients alike.
Akeso, in partnership with MediTrust Health, pioneers Therapeutic-Result-Linked coverage solutions. This model upgrades from medication access to holistic health management, and leverages intelligent risk control and dynamic anti-fraud claims verification systems.
Offices
Shanghai
Beijing
Shenzhen
Nantong
Xi’an
Marketing Activities
marketing@meditrusthealth.com
Address
12/F, Building A, Fenglin Plaza 380 Fenglin Road, Xuhui District, Shanghai
Address
12/F, Building A, Fenglin Plaza 380 Fenglin Road, Xuhui District, Shanghai
电子营业执照
沪公网安备31010402003664号@Copyright©MediTrust Health 2019镁信健康官方网站 | 上海镁信健康科技集团股份有限公司